Michael S Vincent - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Michael S Vincent

Showing results (1-10 of 40) with videos related to

Pageof 4

Sort By:

Nature Immunology|May 30, 2003

Understanding the function of CD1-restricted T cellsMichael S Vincent, Jenny E Gumperz, Michael B Brenner

Methods in Molecular Biology (Clifton, N.J.)|March 7, 2018

QuickRNASeq: Guide for Pipeline Implementation and for Interactive Results VisualizationWen He, Shanrong Zhao, Chi Zhang, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2005

CD1a-, b-, and c-restricted TCRs recognize both self and foreign antigensMichael S Vincent, Xiaowei Xiong, Ethan P Grant, et al.

Drug Discovery Today|November 1, 2020

Reviving an R&D pipeline: a step change in the Phase II success rateShuang S Wu, Kathy Fernando, Charlotte Allerton, et al.

Journal of Occupational and Environmental Medicine|September 16, 2011

Markers of inflammation in alveolar cells exposed to fine particulate matter from prescribed fires and urban airTheodore A Myatt, Michael S Vincent, Lester Kobzik, et al.

Drug Discovery Today|March 9, 2024

Master protocols and other innovative trial designs in inflammation and immunology to expedite clinical drug developmentElena Peeva, Anindita Banerjee, Christopher Banfield, et al.

Nature Immunology|November 5, 2002

CD1-dependent dendritic cell instructionMichael S Vincent, David S Leslie, Jenny E Gumperz, et al.

The Journal of Experimental Medicine|December 18, 2002

CD1-mediated gamma/delta T cell maturation of dendritic cellsDavid S Leslie, Michael S Vincent, Franca M Spada, et al.

Journal of the American Academy of Dermatology|April 10, 2022

Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase 2b, randomized, double-blind, placebo-controlled studyChristopher Tehlirian, Ravi Shankar P Singh, Vivek Pradhan, et al.

Journal of Clinical Pharmacology|September 29, 2023

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PF-06817024 in Healthy Participants, Participants with Chronic Rhinosinusitis with Nasal Polyps, and Participants with Atopic Dermatitis: A Phase 1, Randomized, Double-Blind, Placebo-Controlled StudySpencer I Danto, Nikolaos Tsamandouras, Padmalatha Reddy, et al.

Pageof 4

Search research articles

Showing results (1-10 of 40) with videos related to

Sort By:

Pageof 4

Nature Immunology|May 30, 2003

Understanding the function of CD1-restricted T cellsMichael S Vincent, Jenny E Gumperz, Michael B Brenner

Methods in Molecular Biology (Clifton, N.J.)|March 7, 2018

QuickRNASeq: Guide for Pipeline Implementation and for Interactive Results VisualizationWen He, Shanrong Zhao, Chi Zhang, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2005

CD1a-, b-, and c-restricted TCRs recognize both self and foreign antigensMichael S Vincent, Xiaowei Xiong, Ethan P Grant, et al.

Drug Discovery Today|November 1, 2020

Reviving an R&D pipeline: a step change in the Phase II success rateShuang S Wu, Kathy Fernando, Charlotte Allerton, et al.

Journal of Occupational and Environmental Medicine|September 16, 2011

Markers of inflammation in alveolar cells exposed to fine particulate matter from prescribed fires and urban airTheodore A Myatt, Michael S Vincent, Lester Kobzik, et al.

Drug Discovery Today|March 9, 2024

Master protocols and other innovative trial designs in inflammation and immunology to expedite clinical drug developmentElena Peeva, Anindita Banerjee, Christopher Banfield, et al.

Nature Immunology|November 5, 2002

CD1-dependent dendritic cell instructionMichael S Vincent, David S Leslie, Jenny E Gumperz, et al.

The Journal of Experimental Medicine|December 18, 2002

CD1-mediated gamma/delta T cell maturation of dendritic cellsDavid S Leslie, Michael S Vincent, Franca M Spada, et al.

Journal of the American Academy of Dermatology|April 10, 2022

Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase 2b, randomized, double-blind, placebo-controlled studyChristopher Tehlirian, Ravi Shankar P Singh, Vivek Pradhan, et al.

Journal of Clinical Pharmacology|September 29, 2023

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PF-06817024 in Healthy Participants, Participants with Chronic Rhinosinusitis with Nasal Polyps, and Participants with Atopic Dermatitis: A Phase 1, Randomized, Double-Blind, Placebo-Controlled StudySpencer I Danto, Nikolaos Tsamandouras, Padmalatha Reddy, et al.

Pageof 4